Behandlung des Reizdarmsyndroms

Die verschiedenen Formen des Reizdarm-Syndroms sind nicht einfach zu behandeln. Oft sind Medikamente nicht sehr wirksam. Primär empfiehlt sich der Versuch, mit gezielten diätetischen Massnahmen eine Besserung herbeizuführen. Im "Medical Letter on Drugs and Therapeutics" ist eine Übersicht zum Reizdarm-Syndrom erschienen, die hier zusammengefasst wird.

The Medical Letter on Drugs and Therapeutics.

Archives of Internal Medicine ◽

10.1001/archinte.1964.00280120128059 ◽

1964 ◽

Vol 113 (6) ◽

pp. 928

Author(s):

John S. Chapman

Keyword(s):

THE MEDICAL LETTER

The Lancet ◽

10.1016/s0140-6736(62)91928-1 ◽

1962 ◽

Vol 279 (7235) ◽

pp. 901

Keyword(s):

The Medical Letter Handbook of Adverse Drug Interactions

Critical Care Medicine ◽

10.1097/00003246-198608000-00033 ◽

1986 ◽

Vol 14 (8) ◽

pp. 757

Author(s):

Alan T. Marty

Keyword(s):

Drug Interactions ◽

A Medical Letter Statement on Smoking and Lung Cancer

CA A Cancer Journal for Clinicians ◽

10.3322/canjclin.10.2.58 ◽

1960 ◽

Vol 10 (2) ◽

pp. 58-59

Keyword(s):

Lung Cancer ◽

Book Review: Drugs of Choice, 17th Edition: Selected Articles from Treatment Guidelines with Updates from The Medical Letter

Annals of Pharmacotherapy ◽

10.1345/aph.1m446 ◽

2010 ◽

Vol 44 (1) ◽

pp. 228-228

Keyword(s):

Treatment Guidelines ◽

Phenindione reconsidered

10.1136/dtb.1.14.56 ◽

1963 ◽

Vol 1 (14) ◽

pp. 56.1-57

Keyword(s):

Toxic Effects ◽

In Britain phenindione is more frequently prescribed than are the coumarins. A year ago the toxic effects of phenindione were discussed in the British edition of The Medical Letter (1962, 1, 45), and the case put for and against the drug. Reports of renal and other damage published since then support the more adverse view.

Chronisch-entzündliche Darmkrankheiten

pharma-kritik ◽

10.37667/pk.2014.950 ◽

2015 ◽

Vol 36 (online) ◽

Author(s):

Felix Schürch

Keyword(s):

Tnf Alpha ◽

Medical Letter ◽

Chronisch Entzündliche

Wie eine Zusammenfassung eines Textes aus dem «Medical Letter on Drugs and Therapeutics» zeigt, hat sich gegenüber unserer im Jahr 2003 veröffentlichten Übersicht zur Therapie der chronisch-entzündlichen Darmkrankheiten nicht sehr viel geändert. Nach wie vor sollen vor dem Einsatz von TNF-alpha-Hemmern die «konventionellen» Therapieoptionen (Aminosalizylate, Kortikosteroide, Immunsuppressiva) optimal ausgenützt werden.

Tremonil

10.1136/dtb.1.5.19 ◽

1963 ◽

Vol 1 (5) ◽

pp. 19-20

Keyword(s):

Neurosurgical Procedures ◽

Residual Symptoms ◽

Medical Letter ◽

Beneficial Action ◽

Autonomic Disturbances

Thiaxanthen (Tremonil - Wander) is recommended for Parkinsonism of any cause, for residual symptoms following neurosurgical procedures and for senile tremor. It is claimed not only to be particularly effective against tremor, but also to reduce rigidity and to have a “beneficial action on the psychic and autonomic disturbances often present in” Parkinsonism. Unfortunately thiaxanthen seems to be more effective in controlling fine tremor in Parkinsonism than in controlling the coarse tremor which is so much commoner. When tremor is reduced it may recur after 1 – 2 months, when it will fail to respond to increased dosage (K. Hartmann-v. Monakow, Schweiz. med. Wschr. 1960, 90, 1070). Tremor may also on occasion be worsened by thiaxanthen (H. P. Schulz, Med. Klin. 1961, 56, 2174). The drug has antihistamine and atropine-like effects. It is chemically related to chlorprothixene (Taractan - Roche), reviewed in The Medical Letter, Brit. ed. 1962, 1, 57.

The medical, letter, brit. ed.: complete index

10.1136/dtb.2.4.16-a ◽

1964 ◽

Vol 2 (4) ◽

pp. 16.2-16

Keyword(s):

Medical Letter ◽

Complete Index

Free copies of this index are now available on request.

Androgenic hormones in anaemia

10.1136/dtb.2.19.75 ◽

1964 ◽

Vol 2 (19) ◽

pp. 75-76

Keyword(s):

Breast Cancer ◽

Aplastic Anaemia ◽

Anabolic Steroids ◽

Male Hypogonadism ◽

Medical Letter ◽

The Many

Despite the many claims made (see Medical Letter, Brit. ed. 1962, 1, 38), androgens and the anabolic steroids related to them have been shown to be of value only in male hypogonadism, in breast cancer in women after the menopause and in some patients with myelofibrosis and aplastic anaemia.